IntegraGen SA (EPA:ALINT)
France flag France · Delayed Price · Currency is EUR
0.1520
+0.0035 (2.36%)
At close: Jan 30, 2026

IntegraGen Company Description

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France.

The company’s genomic pharma services DNA sequencing for oncology and rare disease research; and NGS testing for cancer research.

It also provides MERCURY, an online biological interpretation tool for oncology intended to assist pathologists and oncologists in transforming raw data obtained through high-throughput sequencing into a molecular report for translational and clinical research use; Galileo, a cloud-based app for dynamic exporation of RNA-Seq expression data; and GeCo, a genomic consulting service that offers researchers with access to biostatistics and bioanalytics experts.

IntegraGen SA was incorporated in 2000 and is headquartered in Évry, France. IntegraGen SA operates as a subsidiary of OncoDNA SA.

IntegraGen SA
IntegraGen logo
CountryFrance
Founded2000
IndustryBiotechnology
SectorHealthcare
Employees40
CEOBerengere Genin

Contact Details

Address:
Genopole Campus 1 BAt. 8
Évry, Ile-de-France 91000
France
Phone33 1 60 91 09 00
Websiteintegragen.com

Stock Details

Ticker SymbolALINT
ExchangeEuronext Paris
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberFR0010908723
SIC Code2835

Key Executives

NamePosition
Berengere GeninGeneral Manager
Anne PhilippiCo-Founder and Director of Bio-Statistics and Genetic Epidemiology
Beatrice CosperecLegal Manager
Celine CaperaSales Manager
Manuelle PuisantDirector of Human Resources